Haemophagocytic lymphohistiocytosis after intravesical BCG administration for bladder cancer presenting with multiorgan failure

Bacillus Calmette-Guérin (BCG), is administered intravesically as an adjuvant immunotherapy for the treatment of non-muscle invasive bladder cancer. While mild non-infectious problems can occur in up to 85 % of cases, significant local and systemic complications have been reported in 1–5 % of cases....

Descripción completa

Detalles Bibliográficos
Autores principales: Liatsos, G. D., Manousopoulou, G., Poulaki, A., Iliaki, A., Mariolis, I., Vassilopoulos, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569663/
https://www.ncbi.nlm.nih.gov/pubmed/37841100
http://dx.doi.org/10.1099/acmi.0.000670.v3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569663/
https://www.ncbi.nlm.nih.gov/pubmed/37841100
http://dx.doi.org/10.1099/acmi.0.000670.v3

Ejemplares similares